Ouye Sub-Q Plus

€ 29.00

(3.5 stars) • 10 reviews

Ouye Sub‑Q Plus is a premium, CE-certified dermal filler formulated with cross-linked hyaluronic acid (HA) and 0.3% lidocaine, designed specifically for subcutaneous injections to restore facial volume and smooth deep wrinkles.

In stock – delivered within 1–3 business days

Interested in bulk orders? Contact us at contact@toxify.shop
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Category

Filler

Brand

Ouye

Manufacturer

S. Thepharm Co. Ltd.

SKU

OUYE-SUB-Q-PLUS-1.0

Volumen

1.0ml

Product Specifications:

Concentration

  • Hyaluronic Acid (HA): 24 mg/ml
  • Lidocaine: 0.3%
  • Monophasic cross-linked gel

Indication

  • Deep wrinkle correction (e.g., nasolabial folds, marionette lines)
  • Facial contouring for cheeks, chin, jawline
  • Volume restoration in subcutaneous tissue
  • Ideal for areas requiring structural support

Contents of the set

  • 1 x 1.0 ml prefilled syringe
  • 2 x needles

Effect Duration

Immediate visible enhancement post-injection

Effects lasting approximately 9 to 12 months depending on the treated area, patient metabolism, and product formulation

Brand

Ouye

The Ouye filler line features advanced UHD technology to create a monophasic, high-viscosity gel that offers excellent volume retention and structural support. The Perfect Monophasic structure ensures even distribution, minimal migration, and controlled outcomes. This line includes Fine, Deep, and Sub‑Q variants to address various treatment depths and aesthetic needs.

Manufacturer

S. Thepharm Co., Ltd.

S. Thepharm Co., Ltd. is a South Korean biotechnology company specializing in anti-aging cosmetic solutions. The company utilizes advanced cell-therapy and dermal science technologies to develop injectable aesthetic products with enhanced safety, biocompatibility, and effectiveness. As the manufacturer of Ouye Sub‑Q Plus, S. Thepharm is committed to delivering reliable and innovative solutions for the global aesthetic medicine market.